Table 3.
Changes in body weight gains in mice with NTX-induced muscle atrophy.
Groups | Body weights (g) | Body weight gains during the test article treatment period (g) [B − A] | ||
---|---|---|---|---|
At NTX | At 14 days after NTX, first administration [A] | Sacrifice [B] | ||
Controls | ||||
Sham | 34.48 ± 1.12 | 32.80 ± 1.26 | 34.84 ± 1.27 | 2.04 ± 1.10 |
NTX | 34.33 ± 0.98 | 32.00 ± 1.18 | 33.69 ± 1.62 | 1.69 ± 1.32 |
Reference | ||||
Oxymetholone | 34.71 ± 1.42 | 32.47 ± 2.31 | 34.58 ± 3.22 | 2.11 ± 1.32 |
EESF treated | ||||
500 mg/kg | 34.77 ± 1.59 | 32.82 ± 2.72 | 34.53 ± 2.75 | 1.71 ± 0.98 |
250 mg/kg | 34.26 ± 1.41 | 32.65 ± 1.89 | 36.00 ± 3.31c | 3.35 ± 1.89ab |
125 mg/kg | 34.47 ± 1.68 | 32.63 ± 2.03 | 34.40 ± 2.48 | 1.77 ± 1.19 |
Values are expressed as mean ± S.D. of 10 mice.
a p < 0.05 as compared with sham control mice by the LSD test.
b p < 0.01 and c p < 0.05 as compared with NTX control mice by the LSD test.